RadNet (RDNT) Akcija Kursas
RadNet Kursas
Per pastaruosius 19 metus RadNet pajamos augo 14,3 % kasmet ir pasiekė 2,04 mlrd. USD. Pelnas akcijai mažėjo 11,9 % per metus per pastaruosius 13 metus. RadNet grynoji marža −0,9 % yra sumažėjo palyginti su 1,9 % prieš kelerius metus. RadNet 12 mėn. konsensuso tikslinė kaina yra 78,00 USD, apie virš kursą 10,8 %. Iš 14 analitikų 13 rekomenduoja pirkti — bendras konsensusas yra Pirkti.
RadNet akcijos kaina
Gaukite šiuos duomenis per Eulerpool API
100 000 užklausų/mėn. nemokamai · be kortelės
RadNet akcija ir akcijų analizė
Dažnai užduodami klausimai apie RadNet akciją
RadNet Inc, a leading provider of outpatient diagnostic imaging services, operates an extensive network of imaging centers across the United States. The company's business model revolves around offering a comprehensive range of high-quality imaging services, including MRI, CT scans, ultrasound, and more. RadNet strives to be at the forefront of medical imaging technology and delivers prompt, accurate results to healthcare providers and patients alike. By leveraging its advanced technology, vast infrastructure, and skilled medical professionals, RadNet Inc remains committed to delivering exceptional diagnostic imaging services to enhance patient care and improve overall health outcomes.
RadNet Inc is primarily active in the healthcare services industry.
RadNet Inc faces competition from various players in the market. Some of the main competitors include vRad, Inc., Alliance HealthCare Services, Inc., and Sonic Healthcare Limited. These companies also operate in the medical diagnostics and imaging services industry, offering similar services as RadNet Inc. Competing for market share and customers, RadNet Inc faces challenges in staying ahead of these key adversaries. As technology and innovation continue to shape the industry, RadNet Inc must remain proactive in its strategies to maintain a strong position in the market.
RadNet Inc. is a leading provider of high-quality, cost-effective diagnostic imaging services in the United States. Established in 1981, RadNet has grown to become a trusted name in the healthcare industry. With a network of over 330 outpatient imaging centers, RadNet offers a wide range of imaging services, including MRI, CT scans, X-rays, mammography, and more. The company is dedicated to delivering accurate and timely results to physicians and patients, helping in the early detection and diagnosis of diseases. RadNet continues to innovate and expand its services, making a positive impact on patient care across the nation.
RadNet Inc has achieved several significant milestones. Continuously expanding its network, RadNet has acquired multiple imaging centers across the United States, enhancing its diagnostic and treatment capabilities. The company has also developed innovative technologies and services, establishing itself as a leader in the field of outpatient diagnostic imaging. RadNet has successfully implemented integrated radiology information systems and picture archiving communication systems, improving operational efficiency and patient care. By consistently delivering high-quality imaging services, RadNet has garnered a strong reputation for its commitment to excellence. The company's dedication to advancing medical imaging technologies and expanding access to affordable healthcare has further solidified its position as a prominent player in the industry.
RadNet Inc is primarily present in the United States of America. With its headquarters in California, the company operates a network of outpatient imaging centers across various states. It has a significant presence in states like California, Maryland, New Jersey, New York, and Delaware, providing diagnostic imaging services to patients. RadNet Inc's expansive reach and strategic locations enable it to deliver high-quality imaging services to a wide range of individuals across different regions in the United States.
RadNet Inc represents values of excellence, innovation, and patient-centered care. Their corporate philosophy revolves around providing high-quality, comprehensive diagnostic imaging services to enhance patient outcomes. As a leading national provider of outpatient imaging, RadNet focuses on leveraging advanced technology and expertise to deliver accurate and timely results. By emphasizing patient satisfaction and quality assurance, RadNet Inc ensures their services are reliable, efficient, and accessible. With a commitment to continuous improvement and staying at the forefront of medical advancements, RadNet Inc remains dedicated to delivering exceptional healthcare experiences to patients across the United States.
Analitikai šiuo metu nustato vidutinę RadNet akcijos tikslinę kainą 78,00 USD (mediana: 78,00 USD), t. y. +10,8 % palyginti su paskutine kaina. Konsensusas pagrįstas 14 analitikų reitingais.
14 analitikai šiuo metu vertina RadNet akciją: 13 rekomenduoja pirkti, 1 laikyti ir 0 parduoti. 2026 m. analitikai tikisi, kad RadNet gaus 2,51 mlrd. USD pajamų ir 0,51 USD pelno akcijai.
Pagal dabartinį kursą RadNet akcija kainuoja 62,78 EUR (70,41 USD).
RadNet akcija (RDNT) kotiruojama 3 biržose, įskaitant: NASDAQ (RDNT), SIX (Zürich) (PQIA.SW), Frankfurt (PQIA.F).
RadNet Inc is a leading company in medical imaging and diagnosis, offering a wide range of services in various areas. The company operates and owns a network of radiology clinics and diagnostic centers in the United States, known for its high quality and reliability in disease diagnosis, treatment, and prevention. RadNet operates in three main business areas: medical imaging, oncology, and radiology information systems. Medical imaging is one of RadNet's key business areas, focusing on diagnostic imaging services such as mammography, x-rays, CT scans, MRI scans, ultrasound, and oncologic imaging services for cancer and other diseases diagnosis. Oncology is another important business area for RadNet, offering advanced radiation therapy and medical oncology services for cancer treatment. Through partnerships and acquisitions of other companies, RadNet also has access to all major therapy options and technologies in oncology. Radiology information systems are another important business area for RadNet, focusing on developing efficient and innovative systems for managing images, reports, and patient data. The company also provides training and consulting services for the implementation of radiology information systems, as well as customizable software solutions for healthcare facilities. In addition to its core business areas, RadNet also offers specialized products and services, such as radiology software for image processing, online referral services for patients, and online diagnostic services to support specialists. RadNet operates over 340 locations and employs over 8,100 staff. The company is committed to providing high-quality healthcare at fair prices, making it a preferred provider for healthcare facilities, insurance companies, and patients in many regions of the USA. RadNet's business model is based on the goal of playing a leading role in global medical imaging and diagnosis through investments in innovative technologies, partnerships, and acquisitions of companies, as well as improving healthcare delivery. RadNet also seeks to expand the clinical knowledge and experience of its staff to further enhance the quality of services offered. Through training and professional development, the personnel will be able to utilize the latest diagnostic and treatment methods, providing optimal care for patients. In summary, RadNet's business model aims to offer a wide range of services in medical imaging and diagnosis to enhance disease diagnosis and treatment. The company strives to gain a competitive advantage and improve patient well-being through investments in innovative technologies and partnerships with other companies, as well as investments in training and professional development for its staff.
tikėtina pelnas RadNet yra 2,51 mlrd. USD. Šis skaičius grindžiamas dabartiniais finansiniais duomenimis ir atspindi įmonės verslo rezultatus.
tikėtina grynasis pelnas RadNet yra 38,45 mln. USD. Grynasis pelnas atspindi įmonės pelningumą po visų išlaidų atimties.
Kainų ir nuomos santykis (KGV) RadNet šiuo metu yra 137,69. KGV lygina dabartinę akcijos kainą su pelnu už akciją ir padeda investuotojams įvertinti RadNet akcijos vertę.
Kainų ir pardavimų santykis (KUV) RadNet šiuo metu yra 2,11. KUV lygina rinkos kapitalizaciją su metinėmis pajamomis ir yra RadNet akcijos įvertinimo metrika.
Eulerpool kokybės balas RadNet yra 4/10.
RadNet ISIN yra US7504911022. ISIN (International Securities Identification Number) yra pasaulinė unikali vertybinių popierių identifikacijos sistema.
RadNet WKN yra A0LFMZ. WKN (Wertpapierkennnummer) yra šešiaženklė vokiška vertybinių popierių identifikacijos sistema.
RadNet prekybos žymė yra RDNT. Ši biržos žymė naudojama RadNet akcijoms prekiauti biržoje.
RadNet akcija
RadNet Pagrindiniai konkurentai
RadNet Biržos simbolis
RadNet FIGI
Visos RadNet pagrindinės charakteristikos ir giluminė analizė
Mūsų akcijų analizė RadNet akcijai apima svarbius finansinius rodiklius, tokius kaip apyvarta, pelnas, P/E santykis, P/S santykis, EBIT, taip pat informaciją apie dividendes. Be to, mes nagrinėjame aspektus, tokius kaip akcijos, rinkos kapitalizacija, skolos, nuosavas kapitalas ir įsipareigojimai RadNet. Jei ieškote išsamesnės informacijos šiais klausimais, mūsų poskyriuose galite rasti išsamias analizes: